Merck & Company, Inc.: quarterly results
Price
$147.76
November 13, 2026Market cap $365B
What Ploutos Investor adds for Merck & Company
Part of Ploutos Investor, €9.99 a month
- The full history: 17 fiscal years, from 2009
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Results, quarter by quarter
When the company put out each quarter's results (its 8-K, item 2.02), what they showed against the same quarter a year before, and how the stock moved on the first session after.
Next results
last Oct 29, 2026next Jan 29, 2027
An estimate from when it has reported before, which has been regular. The company announces the date itself.
The first session after results
±1.9%average move, either way
3 times upof the last 41 times down
Largest: +3.8% on Oct 29, 2026 (Q3 2026).
How the stock moved after each release
The close of the first session after the results against the close before them.
MRK that sessionS&P 500 the same day
Every release
Revenue and diluted EPS of the quarter reported, with the change against the same quarter a year before.
- Q3 2026Stock, next session+3.8%
- Q2 2026Stock, next session+0.2%
- Q1 2026Stock, next session-1.6%
- Q4 2025Stock, next session+2.2%
| Quarter | Released | Revenue | EPS | Stock, next session | S&P 500 | Filing |
|---|---|---|---|---|---|---|
| Q3 2026 | Oct 29, 2026before the close | $18.1B+4.7% | $2.04-12.1% | +3.8% | -0.3% | 8-K |
| Q2 2026 | Aug 4, 2026before the close | $16.6B+5.1% | -$0.54-130.7% | +0.2% | +1.8% | 8-K |
| Q1 2026 | Apr 30, 2026before the close | $16.3B+4.9% | -$1.72-185.6% | -1.6% | +1.0% | 8-K |
| Q4 2025 | Feb 3, 2026before the close | $16.4B+5.0% | $1.19-19.6% | +2.2% | -0.8% | 8-K |
Every release
MRK's results days and the share's move after each, from Q2 2010 to Q3 2025, 64 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 8 quarters.
Times are the SEC's acceptance of the 8-K, in New York time: before 16:00 the market traded on it that day, after it the next day. A move on a results day has other causes too, and says nothing about the next one.
The full analysis
What do Merck & Company's filings show?
The results say what Merck & Company reported. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.